The benefits of avocado are already known to everyone. It is full of fiber, it contains more potassium than bananas, as well as monosaturated fatty acids that are good for the heart, it is full of vitamins (A, B1, B6, C, E, K) and antioxidants and it provides the necessary satiety to encourage you to include it in any diet.
Moreover, it was proved that this super food can help combat not only heart disease but also obesity and arthritis and recent research showed that the nutritious avocado might help fight leukemia, even in its acute form.
Acute Myeloid leukemia is considered to be one of the most severe diseases and many people who suffer from it have few chances of survival. It was reported that 90 percent of the people who are over 65 years old die of AML in the first five years after it has been diagnosed. This is mainly because there is very little treatment available for patients who have AML.
However, there is good news for these people because recent studies carried out at the University of Waterloo, in collaboration with the Centre for Commercialization of Regenerative Medicine, revealed that a new type of drug derived from avocado can improve life quality and survival rates for people who have acute myeloid leukemia.
The lead researcher, professor Paul Spagnuolo, showed how a lipid from avocado can target the leukemia stem cells, which cause the disease to spread. These lipids, called avocatin B, can help combat AML by addressing only the stem cells which are extremely dangerous, because they can affect blood cells, without affecting the healthy ones.
“We’ve performed many rounds of testing to determine how this new drug works at a molecular level and confirmed that it targets stem cells selectively, leaving healthy cells unharmed.” said professor Paul Spagnuolo.
He also explained that what avocation B does is not only to eliminate the source of AML (stem cells) but it also has benefic effects on the body because it is not toxic.
The drug is not yet available on the market but the researchers hope it will be used quite soon. They are still experimenting it for a Phase I trial and they are very optimistic about its outcome.
The results of the research were published in a very prestigious oncology journal called Cancer Research.
Image Source: Getfit